The Health Affairs blog questions the American Heart Association's maximalist approach with the use of statins. The issues sound familiar. The policy implications of these guidelines are staggering. Estimates show that if these recommendations are fully implemented, close to a third of all Americans will be placed on a statin. But these developments beg the … Continue reading The Unintended Consequences Of Medical “Maximalism”
This weekend is the fist time I recall seeing Bill White discuss the concept of community recovery capital. I've heard him discuss community recovery and the ecology of recovery, but I think I must have missed community recovery capital. The prognosis for community recovery is influenced by the ratio between problem prevalence, severity, and complexity … Continue reading Community Recovery Capital
These images speak for themselves. Here are a couple of important sentences: Between 1999 and 2009, drug poisoning deaths grew by 394 percent in rural areas and 279 percent for large metropolitan areas, according to the CDC’s county-level look at the data. According to the CDC, roughly 60 percent of all OD deaths in 2010 … Continue reading Drug Overdose Deaths Are Increasing Pretty Much Everywhere
This will be my post in response to the NY Times' series on Suboxone. This post originally ran on 7/19/13 and addressed a lot of our concerns. * * * I've been catching a lot of heat recently for posts about Suboxone and methadone. (For the sake of this post, lets refer to … Continue reading What makes treatment effective?
The NY Times has a new piece on Suboxone. First, on its blockbuster status: Suboxone is the blockbuster drug most people have never heard of. Surpassing well-known medications like Viagra and Adderall, it generated $1.55 billion in United States sales last year, its success fueled by an exploding opioid abuse epidemic and the embrace of federal officials … Continue reading Addiction Treatment With a Dark Side
From the NY Times: Addiction experts protested loudly when the Food and Drug Administration approved a powerful new opioid painkiller last month, saying that it would set off a wave of abuse much as OxyContin did when it first appeared. An F.D.A. panel had earlier voted, 11 to 2, against approval of the drug, Zohydro, … Continue reading Who’s guarding the hen house?
Bill White has a new paper on Recovery and Harm Reduction in Philadelphia. Here's a quote he offered in a blog post introducing the paper: Traditional harm reduction programs have pioneered low threshold services, but they have often also been characterized by low expectations. Our vision is to expand low threshold services that at the same … Continue reading Recovery and Harm Reduction
David Best recently wrote a piece on addiction and quality of life. On the role of community in recovery: At the heart of the recovery movement is a shift of emphasis away from “treatment” as a model reliant on professionally delivered interventions. Rather, the movement sees the recovery journey an intrinsically social process and … Continue reading Addiction and quality of life
Yoga of 12-Step Recovery (Y12SR) thinks of itself as an adjunct to 12 step recovery. Founded in 2012, The Y12SR Foundation is a program of Off the Mat, Into the World® (OTM). Our mission is to empower the lives of individuals and families affected by substance and behavioral addictions with relapse prevention practices that enhance … Continue reading Tribes of the recovering community
Bill White on the importance of primary care: The Philadelphia survey goes beyond affirming the significant prevalence of recovery in the general population to provide a detailed profile of the health of people in recovery. The results are sobering. People in recovery, compared to citizens not in recovery, are twice as likely to describe their … Continue reading How full do you want your recovery to be?